Avalglucosidase Alfa Extension Study
NCT02032524
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
19
Enrollment
INDUSTRY
Sponsor class
Conditions
Glycogen Storage Disease Type II Pompe Disease
Interventions
DRUG:
Avalglucosidase Alfa
Sponsor
Genzyme, a Sanofi Company